ABeWER Clinical Intelligence
Why the SAFESiT® Multicycle Alternating Pressure Air Cushion is redefining pressure injury prevention for wheelchair users, long-term seated patients, and high-dependency care environments.
Peer-aligned clinical content | EU MDR 2017/745 Certified | CE Mark
Section 1: The Clinical Problem
The Overlooked Danger of the Seated Position
Pressure injuries do not occur only in bed. For wheelchair users, post-operative patients, individuals undergoing rehabilitation, and those confined to prolonged seated positioning, the seated posture generates some of the highest interface pressures the human body endures, concentrated directly over the ischial tuberosities and sacrum.
Pressure injuries, also known as pressure ulcers, decubitus ulcers, or bedsores, develop when sustained mechanical loading compresses soft tissue against bone, restricting capillary blood flow and triggering a cascade of ischaemia, inflammatory response, and irreversible tissue necrosis. The National Pressure Injury Advisory Panel (NPIAP) classifies these wounds across Stages 1 through 4, with Stage 4 representing full-thickness tissue loss extending into muscle and bone, injuries associated with protracted hospitalisation, septic complications, and significantly elevated mortality risk.
What is frequently underappreciated in clinical practice is the disproportionate vulnerability of the seated patient. Interface pressures over the ischial tuberosities in a standard seated position can exceed 300 mmHg, nearly eight times the capillary closing pressure of 32 mmHg. Without active pressure redistribution, even two hours of uninterrupted sitting is sufficient to initiate deep tissue damage in high-risk individuals.
Clinical Insight. Standard foam or gel cushions are passive devices. They attenuate peak pressures at the point of contact, but they cannot eliminate sustained loading across extended sitting periods. For patients who cannot independently reposition, static support surfaces are demonstrably insufficient as a standalone intervention.
This is the clinical gap that ABeWER’s SAFESiT® Multicycle Alternating Pressure Air Cushion was engineered to address.
Section 2: Technology & Mechanism of Action
Active, Intelligent, Automated: The SAFESiT® Mechanism
SAFESiT® is not a cushion that merely softens the seated surface. It is a dynamic, automated therapeutic system that continuously intervenes in the pressure-time relationship, the fundamental variable governing tissue viability in immobile patients.
At the core of SAFESiT® is a multicycle alternating pressure air cell system. The cushion is composed of a matrix of individually addressable air cells that undergo sequential, programmatic inflation and deflation cycles under the control of a compact, whisper-quiet external pump. The effect is a continuously shifting support topography beneath the patient, cyclically transferring load away from high-risk anatomical zones before sustained ischaemia can develop.
Multicycle Alternating Pressure
Sequential inflation and deflation patterns vary pressure across the seating surface in clinically relevant cycles, preventing continuous loading of the ischial tuberosities and sacrum, the primary injury sites in seated patients.
Continuous Low Pressure (CLP) Mode
Between dynamic cycles, SAFESiT® maintains a calibrated baseline pressure, ensuring the support surface never reverts to static loading. CLP provides an additional safety layer during repositioning intervals and mode transitions.
Microclimate Management
Heat and moisture at the skin-surface interface are recognised co-factors in pressure injury pathogenesis. SAFESiT®’s breathable medical-grade cover and dynamic air movement through the cell system support active microclimate regulation, reducing the risk of maceration and secondary skin breakdown.
Immersion and Envelopment Dynamics
Air cell geometry is designed to maximise immersion, the degree to which the body sinks into the support surface, and envelopment, distributing pressure across the widest possible contact area and reducing peak loading at bony prominences.
Multiple Therapy Modes for Individualised Care
Unlike conventional alternating pressure cushions that offer a single fixed cycle, SAFESiT® integrates multiple programmable therapy modes that can be matched to the patient’s clinical risk profile, body habitus, and tolerance. Nurses and wound care specialists can configure cycle frequency, pressure amplitude, and mode selection directly from the external pump’s control panel, without requiring specialist engineering knowledge.
This level of clinical adjustability is critical: no two pressure injury patients are identical. A post-operative bariatric patient with Stage 2 sacral ulceration requires a fundamentally different offloading strategy than a geriatric patient with peripheral vascular disease using a wheelchair for four hours daily. SAFESiT® is built to serve both, and every patient presentation between.
Pressure redistribution is not a passive outcome. It is an active, time-sensitive clinical intervention that demands continuous automation, not periodic manual repositioning.
Section 3: Clinical Nursing Practice
What SAFESiT® Means for Nursing Teams
Pressure injury prevention sits at the heart of nursing practice, and equally at the centre of hospital quality metrics, regulatory compliance, and patient safety reporting. Healthcare-acquired pressure injuries (HAPIs) are preventable adverse events, and their occurrence carries substantial consequences: extended stays, increased infection risk, complex wound care requirements, and in many jurisdictions, financial penalties under value-based care frameworks.
Manual repositioning, the traditional cornerstone of seated pressure management, is labour-intensive, time-dependent, and inherently inconsistent. Repositioning every two hours is the gold-standard recommendation, but in high-occupancy wards, staffing pressures routinely compromise this schedule. The consequence is predictable and well-documented: sustained interface pressure, tissue hypoxia, and injury.
SAFESiT® does not replace nursing judgment. It augments it, providing automated, continuous pressure redistribution that functions independently of repositioning schedules, shift changeovers, or ward capacity pressures.
- Reduces reliance on manual repositioning frequency in seated patients, supporting nursing staff workload without compromising patient outcomes.
- Enables consistent offloading across all shifts, including overnight and weekend periods where staffing ratios are most constrained.
- Supports evidence-based pressure injury prevention protocols aligned with NPIAP, EPUAP, and PPPIA international guidelines.
- Adjustable pressure settings allow nurses to personalise therapy at the bedside, without requiring biomedical or technical input.
- Quiet pump operation minimises patient disruption and maintains the restful environment essential to healing.
- Medical-grade, wipe-clean covers with sealed surfaces support infection prevention and control (IPC) compliance and reduce cross-contamination risk.
Section 4: Device Specifications
Technical Specifications at a Glance
| Parameter | SAFESiT® Specification |
|---|---|
| Cushion type | Multicycle automated alternating pressure air cushion |
| Therapy modes | Multiple dynamic alternating pressure modes plus Continuous Low Pressure (CLP) |
| Pressure range | Individually adjustable based on patient weight and clinical profile |
| Cushion dimensions | 45 × 45 × 9 cm, standard wheelchair compatible |
| Weight capacity | Up to 180 kg |
| Power supply | Standard mains electrical (UK adapter available) |
| Battery operation | Up to 10 hours continuous operation on integrated lithium rechargeable battery |
| Pump | Compact external pump with quiet operation, suitable for home and clinical environments |
| Cover material | Medical-grade, wipeable, breathable, IPC-compatible |
| Pump warranty | 24 months manufacturer warranty |
| Cushion warranty | 12 months manufacturer warranty |
| Regulatory status | CE certified; EU MDR 2017/745 Medical Device Regulation compliant |
Section 5: Flexibility & Mobility
Designed for Real Clinical Environments and Real Life
Pressure redistribution cannot be a therapy that stops when a patient leaves the ward. Transitions between care settings, transportation to imaging or surgery suites, rehabilitation sessions, home visits, and daily mobility activities represent precisely the moments when therapy interruption is most likely, and when tissue loading from prolonged sitting is most predictable.
Mains Power: Clinical and Home Use
SAFESiT® connects to standard electrical outlets for continuous, stable operation in hospitals, rehabilitation centres, nursing homes, and home care settings. A UK plug adapter is included where required.
Battery Operation: Mobile and Transport Use
An integrated rechargeable lithium battery delivers up to 10 hours of autonomous therapy, maintaining full alternating pressure function during patient transport, ambulance transfer, wheelchair mobility, and community rehabilitation.
Clinical Note: Therapy Interruption Risk. Interruption of pressure redistribution therapy during patient transfer is a well-recognised, but underaddressed, risk factor in pressure injury development. SAFESiT®’s 10-hour battery autonomy ensures that alternating pressure therapy continues seamlessly across care transitions, eliminating the gap that static cushions create the moment a patient moves beyond a power outlet.
Section 6: Patient Populations
Which Patients Benefit Most from SAFESiT®?
SAFESiT® is clinically indicated across a broad spectrum of patient risk profiles, from primary prevention in high-risk individuals to active management as part of a comprehensive wound care plan. Clinical assessment and staging by a qualified practitioner or wound specialist remains essential, particularly for existing pressure injuries at Stage 3 and above.
- Wheelchair users: permanent or extended wheelchair users with limited or absent capacity for independent weight shift and repositioning.
- Hospital inpatients: post-surgical, ICU step-down, and general ward patients requiring prolonged seated positioning during recovery.
- Rehabilitation patients: patients undergoing physiotherapy and mobility retraining, where seated positioning is integral to the therapeutic programme.
- Geriatric and long-term care: elderly patients with reduced mobility, fragile skin integrity, and comorbidities including vascular insufficiency and malnutrition.
- Existing pressure injuries: patients with active wounds (Stages 1 to 4) requiring adjunctive offloading support as part of a multidisciplinary wound management plan.
- Prolonged seated occupations: professional drivers, long-haul operators, and others exposed to sustained seated pressure outside clinical environments.
Section 7: For Distributors & Hospital Procurement
A Compelling Clinical and Commercial Case
For distributors of hospital beds, pressure care mattresses, and medical seating solutions, SAFESiT® fills a critical product gap. The majority of alternating pressure therapy portfolios focus heavily on the mattress segment, leaving the seated patient population significantly underserved by active, automated technology. SAFESiT® is the alternating pressure cushion that hospital procurement teams, wound care coordinators, and nursing directors have been seeking.
Market Differentiation. While alternating pressure mattresses are now widely specified across acute and community settings, active alternating pressure cushions with multicycle technology and battery autonomy remain a rare category. SAFESiT® occupies this position uniquely, as a CE-certified, EU MDR-compliant device with clinical-grade credentials and a clearly defined patient population.
Hospital procurement teams evaluating support surface investments should weigh the total cost of pressure injury management against the acquisition cost of preventive technology. Conservative estimates from NHS England and comparable European health systems place the average direct cost of treating a single hospital-acquired pressure injury at €6,000 to €40,000 depending on severity, with Stage 4 ulcers representing substantially greater resource consumption. Automated, consistently effective prevention technology is not a cost; it is a cost avoidance investment.
What Distributors Can Expect from ABeWER
- CE-certified, EU MDR 2017/745 compliant device, ready for European market placement without additional regulatory burden.
- Exclusive distributor network model: ABeWER operates through established partners, ensuring protected territories and competitive margin structures.
- Clinical and technical sales support materials, including product training, device demonstration units, and evidence documentation.
- Dual warranty coverage: 24 months on the pump, 12 months on the cushion, providing distributor and end-user reassurance.
- EXW shipping terms with dedicated export management, clarity on logistics from the first order.
Section 8: Evidence-Aligned Design
The Evidence Basis for Active Seated Pressure Redistribution
The foundational science underpinning SAFESiT® is well-established in the pressure injury literature. The NPIAP/EPUAP/PPPIA Clinical Practice Guideline recommends the use of reactive or active support surfaces for patients identified at elevated risk of pressure injury, with active alternating pressure surfaces carrying the strongest evidence base for sustained offloading efficacy.
The core biomechanical principle is time and pressure. Tissue damage is a function not of peak pressure alone, but of the integral of pressure over time, the sustained loading that restricts perfusion and initiates necrotic pathways. Multicycle alternating pressure technology directly addresses this variable: by periodically offloading each anatomical zone before the ischaemia threshold is reached, the cumulative pressure-time burden is systematically interrupted, protecting tissue viability even in the highest-risk patients.
SAFESiT®’s multicycle architecture goes further than simple two-phase alternation. By integrating multiple mode options and a continuous low pressure baseline, the system provides clinicians with a therapeutically flexible platform, one that can be precisely calibrated to individual tissue tolerance rather than applied as a population-level average.
ABeWER designs its products at the intersection of clinical evidence, engineering precision, and practical care delivery, because technology that cannot be integrated seamlessly into the ward environment will never achieve its potential, regardless of its laboratory performance.
Ready to Bring SAFESiT® to Your Patients?
Whether you are a nurse exploring clinical procurement options, a hospital purchasing team evaluating support surface investments, or a medical device distributor looking to expand your pressure care portfolio, ABeWER’s team is ready to support your next step.